Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. August 2012 16:23 ET | Quelle: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Three Months Ended June 30, 2012

NORTHVALE, N.J., Aug. 14, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
09. August 2012 08:01 ET | Quelle: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 First Quarter Investor Conference Call on Wednesday, August 15, 2012

NORTHVALE, N.J., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and controlled...
29. Juni 2012 16:55 ET | Quelle: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2012

NORTHVALE, N.J., June 29, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
27. Juni 2012 08:00 ET | Quelle: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year Ending March 31st, 2012 Investor Conference Call on Tuesday, July 3, 2012

NORTHVALE, N.J., June 27, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
13. Juni 2012 11:46 ET | Quelle: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Bridge Loan Facility

NORTHVALE, N.J., June 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that it has entered into a bridge loan agreement ("Loan") with Jerry Treppel,...
22. Mai 2012 09:31 ET | Quelle: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Issuance of U.S. Patent for Abuse Resistant Oral Dosage Formulation

NORTHVALE, N.J., May 22, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced the issuance of U.S Patent No. 8,182,836 entitled "Abuse-Resistant Oral...
22. März 2012 16:15 ET | Quelle: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Signs an Agreement With a Private Hong Kong-Based Company to Develop a Prescription Pharmaceutical Product in the US

NORTHVALE, N.J., March 22, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that it has entered into an agreement to develop for a...
13. März 2012 08:30 ET | Quelle: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces First Shipment of Generic Hydromorphone Product

NORTHVALE, N.J., March 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today the initial shipment of hydromorphone hydrochloride 8 mg tablets, the generic...
14. Februar 2012 14:47 ET | Quelle: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal 2012

NORTHVALE, N.J., Feb. 14, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing generic and branded oral...
13. Februar 2012 08:30 ET | Quelle: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Discuss Third Quarter 2012 Results of Operations on Wednesday, February 15, 2012

NORTHVALE, N.J., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...

Vorherige Seite